List/Grid

Oncology Subscribe to Oncology

Many older people have mutations linked to leukemia, lymphoma in their blood cells

Many older people have mutations linked to leukemia, lymphoma in their blood cells

At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis. Mutations in the body’s cells randomly accumulate as part of the aging process, and most are harmless Continue reading

New treatment designed to save more eyes from cancer

New treatment designed to save more eyes from cancer

Doctors at Cincinnati Children’s Hospital Medical Center have developed a new technique for treating the eye cancer retinoblastoma to improve the odds for preventing eye loss, blindness or death in children with advanced forms of the disease. Treatments for retinoblastoma have progressed dramatically in recent years, one being a procedure called ophthalmic artery infusion chemotherapy Continue reading

How metastases develop in the liver

How metastases develop in the liver

In order to invade healthy tissue, tumor cells must leave the actual tumor and enter the bloodstream or lymphatic system. Continue reading

New at-risk group identified for gastrointestinal stromal tumors

New at-risk group identified for gastrointestinal stromal tumors

Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors (GIST), which occur primarily in the lining of the stomach and small intestine. One key finding: Patients of Asian descent, who have not previously been identified as an at-risk population, are 1.5 times more likely than other patient groups to be diagnosed with this type of tumor. Results of the study were published this week in Cancer Epidemiology, Biomarkers & Prevention , a journal of the American Association for Cancer Research. Continue reading

One in three people with cancer has anxiety or other mental health challenges

One in three people with cancer has anxiety or other mental health challenges

Researchers in Germany report that nearly a third of more than 2,100 patients with cancer interviewed at inpatient and outpatient care centers experienced a clinically meaningful level of mental or emotional distress that meets the strict diagnostic criteria for mental disorders including anxiety, depressive and adjustment disorders during the prior four weeks. Continue reading

Cancer medicine: New, improved, expensive and exploited?

Cancer medicine: New, improved, expensive and exploited?

Two studies published in the October 2014 issue of Health Affairs by a University of Chicago health economist examine spending on oral anti-cancer drugs as well as a federal program designed to help the poor, which researchers say instead helps hospitals boost profits. The first study, by Rena M. Continue reading

New educational modules harness power of e-learning for pancreatic cancer education

New educational modules harness power of e-learning for pancreatic cancer education

How can healthcare professionals stay on top of the ever-evolving field of pancreatic cancer? The e POSSOM ( e cancer POst Graduate School of Surgery Surgical Oncology Modules) project has launched a series of innovative educational modules to meet the educational needs of post-graduate surgical trainees looking to extend their knowledge on pancreatic cancer Continue reading

Socioeconomic factors, fashion trends linked to increase in melanoma

Socioeconomic factors, fashion trends linked to increase in melanoma

A century’s worth of cultural and historical forces have contributed to the rise in the incidence of melanoma, including changes in fashion and clothing design, according to an intriguing, retrospective research study conducted by investigators in the Ronald O. Perelman Department of Dermatology at NYU Langone Medical Center. Continue reading

Trastuzumab should remain as standard of care for HER2-positive breast cancer, trial suggests

Trastuzumab should remain as standard of care for HER2-positive breast cancer, trial suggests

Analysis of more than 8,000 women who participated in the world’s largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that trastuzumab (Herceptin) should remain the standard of care for this cancer, says a Mayo Clinic researcher. This study, being presented at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, reveals that when used as a single HER2-targeted therapy in addition to standard chemotherapy, trastuzumab offers a better outcome than does lapatinib (Tykerb), says Edith A. Continue reading

Mesothelioma: New Findings On Treatment Options

Mesothelioma: New Findings On Treatment Options

Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid. Continue reading